about
Ultrasound-enhanced polymer degradation and release of incorporated substances.Shape-changing magnetic assemblies as high-sensitivity NMR-readable nanoprobes.Smart approaches to glucose-responsive drug deliveryStimuli sensitive polymers and self regulated drug delivery systems: a very partial reviewMicro-patterned drug delivery device for light-activated drug release.Nanoencapsulation of insulin into zirconium phosphate for oral delivery applications.Thermodynamics of the hydrophobicity in crystallization of insulin.Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin deliveryCervical cancer treatment with a locally insertable controlled release delivery system.The pursuit of perfect control in diabetes.Pulsatile release of parathyroid hormone from an implantable delivery system.Multi-reservoir bioadhesive microdevices for independent rate-controlled delivery of multiple drugs.Managing diabetes with nanomedicine: challenges and opportunitiesPrediction of protein solubility from calculation of transfer free energy.Innovative strategies for co-delivering antigens and CpG oligonucleotides.Bio-responsive polymer hydrogels homeostatically regulate blood coagulationSmart polymers for responsive drug-delivery systems.Real time response polymeric delivery systems.Treating metastatic cancer with nanotechnology.Emerging microtechnologies for the development of oral drug delivery devices.Bioresponsive hydrogels.Responsive materials for self-regulated insulin delivery.PLGA microspheres by Supercritical Emulsion Extraction: a study on insulin release in myoblast culture.Photocaged permeability: a new strategy for controlled drug release.Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats.Bio-inspired synthetic nanovesicles for glucose-responsive release of insulin.Injectable nano-network for glucose-mediated insulin deliveryGlucose-responsive insulin by molecular and physical design.Advances in bioresponsive closed-loop drug delivery systems.Real-time imaging of tunable adenosine 5-triphosphate release from an MCM-41-type mesoporous silica nanosphere-based delivery system.Biomaterials and biotechnology: from the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering.Stimuli-Responsive Delivery of Therapeutics for Diabetes Treatment.Multi-pulse drug delivery from a resorbable polymeric microchip device.Simulation and optimisation of a self-regulating insulin delivery system.Programmable hydrogels.Designing hydrogels for controlled drug delivery.Bioresponsive Hydrogels and MicrogelsUltrasound-triggered noninvasive regulation of blood glucose levels using microgels integrated with insulin nanocapsulesA controlled-release microchip
P2860
Q30502318-A498835A-F7DB-4098-B9D6-54BA07FA83D0Q30662281-C254799E-00E3-4053-90F3-C2E3E0CE1E23Q33742934-B65AE2F8-ED71-4679-B0BC-F2C85DFA4FD3Q34079626-4803FA54-9DBD-4FDD-8288-93893149C34BQ34086350-EC12DBE7-8878-4D21-B77F-FEFEC6E7DCD8Q34140183-7AB6786D-D59F-43B3-BAA5-646845E2616CQ34183984-BAA37C3F-D1DC-45D7-A851-2209B191B21FQ34481917-54C68E4D-3CF0-4E4B-93EF-E7278CDE08C9Q35585268-276FE87F-3752-4BB0-AB1F-1D46EC59719EQ35704111-7C984539-C65B-402E-B33D-ADC37CF370ADQ36102547-1B83B8D1-8C5E-4B59-919E-2E6827E5269DQ36481174-EB70011C-8E2F-4EFE-91A6-13C119AA2D1CQ36574654-4B75F5C4-C4E2-4C13-8528-7D3DC07DBA4BQ36856361-977FE1F2-BD2A-42CC-BFA0-D6BA024C049EQ37130626-8B7F75E4-16FA-430B-9F08-76935B223074Q37137109-9B54DA24-0625-408F-B2B4-DC26F84F3996Q37183542-A3AC0A74-DF97-4C8C-92F0-7FF638EDEDD4Q37672779-1324FCC9-D449-4F92-A908-D9FB8AA93606Q37970910-7550E8CD-0A8D-435C-994C-A76E56272BD6Q38043777-B5092C32-FCC2-4927-AA71-BE86FEF9B1E7Q38066812-E09C7885-88DB-4486-AC72-6493E7FF4946Q38120506-9C85E6D9-5560-4C37-8073-73376DB0D2C0Q39137198-0026B87E-5992-4D91-85D3-71358345C01AQ39369855-00AF3888-E807-495C-9907-2BA7A7687A5BQ41842643-E615FA0A-664E-4607-8818-6C9A1666F8E5Q41974259-B0DC32AB-6815-4839-82C9-31506476C2B6Q42744272-8714CE9B-6696-41F2-A1AA-74A20AA8F930Q44875590-1C0AF2A8-C0A0-4158-9785-85B7548A8AF1Q44877496-A1F7DBB7-7791-44A7-A1D0-8129FC8108B1Q46496788-634E3193-1A0C-46D7-8BF9-8E2C68F1D762Q48233888-BF670365-38CF-4B19-BF2D-70BC801355C2Q50904654-C623A975-6EE0-4D40-9E02-77215AA94594Q51797551-9FA84081-76C3-4818-A02D-5AD25A5EFB85Q52407290-C9AD21D0-484A-4B05-B188-E8EF15F4CC95Q52650887-F69AF6F9-1D78-49B1-A48E-702E1512EF44Q55264903-98955F89-E3FD-4C0B-BADC-364A468EFADDQ57341116-63A5B1F1-6737-457B-8197-2E3BEEBEB037Q57426775-F0D4C430-0058-44BD-8F8A-68626C08D929Q59058736-6E51886F-AD3C-4A07-9C2F-102AC43940CD
P2860
description
1988 nî lūn-bûn
@nan
1988 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Enzymatically controlled drug delivery
@ast
Enzymatically controlled drug delivery
@en
Enzymatically controlled drug delivery.
@nl
type
label
Enzymatically controlled drug delivery
@ast
Enzymatically controlled drug delivery
@en
Enzymatically controlled drug delivery.
@nl
prefLabel
Enzymatically controlled drug delivery
@ast
Enzymatically controlled drug delivery
@en
Enzymatically controlled drug delivery.
@nl
P2093
P2860
P356
P1476
Enzymatically controlled drug delivery
@en
P2093
D Brandenburg
E Mathiowitz
F Fischel-Ghodsian
P2860
P304
P356
10.1073/PNAS.85.7.2403
P407
P577
1988-04-01T00:00:00Z